Back to search
FDAFDA · Food and drugs·Recall number Z-2403-2012

Amplilink (AL) Software 3.2.3 for use with COBAS AMPLICOR, CAP/CA, COBAS TaqMan,and COBAS AmpliPrep/COBAS TaqMan. The software can be used with a Laboratory Information System.

Published September 26, 2012 · Recall initiated: April 23, 2012

Summary

FDA records medical device Class II recall Z-2403-2012, published September 26, 2012 and initiated April 23, 2012. Recalling firm: Roche Molecular Systems, Inc.; Status: Terminated; Reported quantity: 1292 instruments; Lot: 05666678001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

When using a Laboratory Information system (LIS) with automated systems utilizing AMPLILINK software v3.2 series (AL v3.2) there is a potential for wrong results to be assigned to an order.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Molecular Systems, Inc.
Distributor
Nationwide (USA) Distribution
Lot
05666678001
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Amplilink (AL) Software 3.2.3 for use with COBAS AMPLICOR, CAP/CA, COBAS TaqMan,and COBAS AmpliPrep/COBAS TaqMan. The software can be used with a Laboratory Information System. recalled?

Yes. FDA published recall Z-2403-2012 on September 26, 2012. Reported hazard: When using a Laboratory Information system (LIS) with automated systems utilizing AMPLILINK software v3.2 series (AL v3.2) there is a potential for wrong results to be assigned to an order.

What should I do if I have this product?

Voluntary: Firm initiated · Letter